DR. PEUSH BAJPAI - HOD And Consultant Medical Oncology Sciences

Oncologist/Cancer Specialist

About Us
  

DR. PEUSH BAJPAI

HOD And Consultant – Medical Oncology Sciences

Manipal Hospital, Delhi

QUALIFICATION

MBBS | MD General Medicine | Specialist Accreditation In Medical Oncology- European Society Of Oncology (ESMO) Certification | DM (Medical Oncology) Cancer Institute, Adyar, Chennai.

Fellowship & Membership

  • European Society of Medical Oncology (ESMO)
  • ASCO
  • NCR oncology group
  • ISMPO
  • ICON
  • Dwarka IMA
  • SIOP

Languages Spoken

  • English
  • Hindi
  • Tamil

Field of Expertise

  • Breast Cancer Management Gastrointestinal malignancies- Gastric, colo-rectal, hepatocellular carcinoma.
  • Gynaecological Malignancies- Carcinoma Ovary, the endometrium.
  • Hematological Malignancies -Multiple Myeloma, CML, CLL and Autologous Bone marrow transplant
  • Soft-tissue Sarcomas and Osteosarcoma
  • Thoracic Malignancies- Lung Carcinoma
  • Immunotherapy
  • Precision Oncology

Awards & Achievements

  • First prize as a part of a team in a Case presentation at the UK Breast Oncoplasty Masterclass
  • First prize in All India Quiz at Lymphoma leukemia meet at Mumbai organized by European Society of Medical Oncology
  • Best poster in BTG Hong Kong โ€Prospective evaluation of Musculoskeletal events in patients of CML on Imatinib Mesylate and correlation with electrolyte imbalances”

Talks & Publications

  • Bajpai P, Ganesan P. Rajendranath, R. and Sagar TG (2012) CaseReport – “ Rare case of hairy cell leukemia in a patient of head and neck
  • malignancy http://medej.tnmgrmu.ac.in 2 (2)
  • Kandakumar V, Ganesan P, Bajpai P (2011) A rare case of peripheral T-cell lymphoma in one year oldchild Indian J Med Paediatr Oncol. 2011 Oct-Dec; 32(4): 227–229.
  • Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge
  • and Response to Aminophylline. Indian J Hematol Blood Transfus 2014 Sep
  • 12;30(Suppl 1):105-7. Epub 2013 Jun 12. Peush Bajpai et al
  • Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancer Oncol Lett 2018 Sep 2;16(3):3757-3769. Epub 2018 Jul 2.Peush Bajpai et al
  • Pazopanib Monotherapy Is Active in Relapsed and Refractory Metastatic Gastroesophageal Adenocarcinoma and Can Produce Durable Response
  • Peush Bajpai et al.Journal of Gastrointestinal Cancer volume 50, pages943–946(2019)
  • Immune checkpoint inhibitors: Real-world experience from India in advanced solid cancers that have progressed on chemotherapy South Asian J Cancer. 2019 Jan-Mar; 8(1): 65–68. Peush Bajpai et al
  • Submitted for Publication: “ Collusion: The façade and it’s implications on Total pain management in palliative care -IJPC_81_20( Indian Journal of palliative care
  • Bajpai, P entitled “Retrospective analysis of adolescent ALL outcomes on BFM 86 protocol in “Lymphoma & Leukemia “(2012) international conference organized by ICONESCON held at Mumbai
  • Bajpai, P. et al Poster presentation: Cardiac Status in Long Term Survivors after Anthracycline Therapy in Lymphoma a prospective study of 141patients, ICON 2009 Chennai
  • Prospective evaluation of musculoskeletal events in patients of Chronic Myeloid
  • Leukemia – Chronic Phase treated with Imatinib mesylate AND possible
  • correlation with electrolyte imbalances. Asia-Pacific Hematology consortium
  • held during 22- 23 Feb 2013 at Hongkong BTG2013 Abstract (20):20-21
  • A multicenter, open-label, single-arm, phase IV study of Trastuzumab
  • Emtansine in Indian patients with HER2 positive unresectable locally
  • advanced or metastatic breast cancer who have received prior treatment
  • with trastuzumab and a taxane
  • A multi-centre, observational, data collection registry study to monitor the
  • routine clinical use of MABTAS (RITUXIMAB 100 MG / 500 MG
  • CONCENTRATE FOR SOLUTION FOR INFUSION, MANUFACTURED BY
  • INTAS PHARMACEUTICALS LTD) in Indian patients.
  • A Randomized, Double-blind, Multi-center, Multi-national Trial to evaluate
  • the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as
  • a Firstline Immunotherapy Treatment in Patients with Low Tumor Burden
  • Follicular Lymphoma.
  • Coguide for Thesis Diplomate National Board (DNB) Medical Assessment of Toxicity of Chemotherapy in Indian Geriatric patient population and Utility Of CRASH-(Chemotherapy Risk assessment Scale for high age patient.)
  • Have Organized SABCS( San Antonio Breast Cancer update 2016 under the aegis of Delhi Breast Oncology Group.
  • Delhi Breast Oncology group meeting @ Manipal Hospital Dwarka in August 2018
  • Co-Organizer of Best Of SABCS 2018 April 2018
  • Organized workshop at Manipal Hospital Dwarka on Good Clinical Practice ( GCP) on 1st March 2019
  • CME on prostate cancer – CONFLUENCE meeting on Prostate Cancer -12 October 2019
  • Dr Peush Bajpai in an authored article on know the warning signs when to approach your doctor observing the Breast cancer Awareness month in the DNA
  • Languages : English , Hindi, Tamil
  • Gender : Male
Specialities
  • Oncology
Video